Carotid ultrasound for pulmonary arteriovenous malformation screening

Objective: In patients with hereditary hemorrhagic telangiectasia (HHT), pulmonary arteriovenous malformations (PAVMs) can cause serious neurological complications. Our aim was to evaluate the potential of contrast-enhanced Doppler ultrasound (CE-US) of the common carotid artery as a screening test...

Full description

Bibliographic Details
Main Authors: Yanna-Schulze Anita, Schneider Günther, Maßmann Alexander, Gräber Stefan, Geisthoff Urban W.
Format: Article
Language:English
Published: De Gruyter 2015-05-01
Series:Open Medicine
Subjects:
Online Access:http://www.degruyter.com/view/j/med.2015.10.issue-1/med-2015-0040/med-2015-0040.xml?format=INT
_version_ 1831650193495293952
author Yanna-Schulze Anita
Schneider Günther
Maßmann Alexander
Gräber Stefan
Geisthoff Urban W.
author_facet Yanna-Schulze Anita
Schneider Günther
Maßmann Alexander
Gräber Stefan
Geisthoff Urban W.
author_sort Yanna-Schulze Anita
collection DOAJ
description Objective: In patients with hereditary hemorrhagic telangiectasia (HHT), pulmonary arteriovenous malformations (PAVMs) can cause serious neurological complications. Our aim was to evaluate the potential of contrast-enhanced Doppler ultrasound (CE-US) of the common carotid artery as a screening test for detection of PAVMs. Methods: A total of 124 consecutive patients with HHT or a positive family history underwent screening for PAVMs with CE-US and thoracic contrast-enhanced magnetic resonance angiography (CE-MRA). CE-US was performed after receiving (D)-galactose microparticulate, and CE-MRA with gadobenate dimeglumine. Twenty-five patients with confirmed PAVMs were referred to conventional pulmonary catheter angiography (PA). Findings on CE-US and CE-MRA were evaluated using contingency tables and McNemar’s test. Results: Using CE-MRA as the reference test, CE-US had a sensitivity of 100%, a specificity of 87%, and a negative predictive value of 100%. In 25 patients who underwent PA, PAVMs that had been diagnosed on CE-US and CE-MRA were confirmed. Of the PAVMs detected by CE-MRA, 24% were not identified on PA. Conclusion: CE-US is a simple, minimally invasive screening method that can easily be performed in different settings. CE-US can predict PAVMs with high probability of success. CE-US may be a simple alternative to transthoracic echocardiography in the assessment of PAVMs in certain HHT-patients.
first_indexed 2024-12-19T15:04:41Z
format Article
id doaj.art-48661c7a3536461fafec3989c3c4d42f
institution Directory Open Access Journal
issn 2391-5463
language English
last_indexed 2024-12-19T15:04:41Z
publishDate 2015-05-01
publisher De Gruyter
record_format Article
series Open Medicine
spelling doaj.art-48661c7a3536461fafec3989c3c4d42f2022-12-21T20:16:28ZengDe GruyterOpen Medicine2391-54632015-05-0110110.1515/med-2015-0040med-2015-0040Carotid ultrasound for pulmonary arteriovenous malformation screeningYanna-Schulze Anita0Schneider Günther1Maßmann Alexander2Gräber Stefan3Geisthoff Urban W.4Department of Cardiology, Städtisches Krankenhaus Pirmasens gGmbH, Pettenkoferstr. 22, 66955 Pirmasens, GermanyMedical Faculty of the Saarland University, 66421 Homburg/Saar, GermanyDepartment of Diagnostic and Interventional Radiology, Saarland University Hospital, 66421 Homburg/Saar, GermanyDepartment of Medical Biometry, Epidemiology and Medical Informatics, Saarland University Hospital, 66421 Homburg/ Saar, GermanyDepartment of Otorhinolaryngology, Essen University Hospital, 45147 Essen, GermanyObjective: In patients with hereditary hemorrhagic telangiectasia (HHT), pulmonary arteriovenous malformations (PAVMs) can cause serious neurological complications. Our aim was to evaluate the potential of contrast-enhanced Doppler ultrasound (CE-US) of the common carotid artery as a screening test for detection of PAVMs. Methods: A total of 124 consecutive patients with HHT or a positive family history underwent screening for PAVMs with CE-US and thoracic contrast-enhanced magnetic resonance angiography (CE-MRA). CE-US was performed after receiving (D)-galactose microparticulate, and CE-MRA with gadobenate dimeglumine. Twenty-five patients with confirmed PAVMs were referred to conventional pulmonary catheter angiography (PA). Findings on CE-US and CE-MRA were evaluated using contingency tables and McNemar’s test. Results: Using CE-MRA as the reference test, CE-US had a sensitivity of 100%, a specificity of 87%, and a negative predictive value of 100%. In 25 patients who underwent PA, PAVMs that had been diagnosed on CE-US and CE-MRA were confirmed. Of the PAVMs detected by CE-MRA, 24% were not identified on PA. Conclusion: CE-US is a simple, minimally invasive screening method that can easily be performed in different settings. CE-US can predict PAVMs with high probability of success. CE-US may be a simple alternative to transthoracic echocardiography in the assessment of PAVMs in certain HHT-patients.http://www.degruyter.com/view/j/med.2015.10.issue-1/med-2015-0040/med-2015-0040.xml?format=INTHereditary hemorrhagic telangiectasia pulmonary arteriovenous malformation screening contrast-enhanced ultrasound
spellingShingle Yanna-Schulze Anita
Schneider Günther
Maßmann Alexander
Gräber Stefan
Geisthoff Urban W.
Carotid ultrasound for pulmonary arteriovenous malformation screening
Open Medicine
Hereditary hemorrhagic telangiectasia
pulmonary arteriovenous malformation
screening
contrast-enhanced ultrasound
title Carotid ultrasound for pulmonary arteriovenous malformation screening
title_full Carotid ultrasound for pulmonary arteriovenous malformation screening
title_fullStr Carotid ultrasound for pulmonary arteriovenous malformation screening
title_full_unstemmed Carotid ultrasound for pulmonary arteriovenous malformation screening
title_short Carotid ultrasound for pulmonary arteriovenous malformation screening
title_sort carotid ultrasound for pulmonary arteriovenous malformation screening
topic Hereditary hemorrhagic telangiectasia
pulmonary arteriovenous malformation
screening
contrast-enhanced ultrasound
url http://www.degruyter.com/view/j/med.2015.10.issue-1/med-2015-0040/med-2015-0040.xml?format=INT
work_keys_str_mv AT yannaschulzeanita carotidultrasoundforpulmonaryarteriovenousmalformationscreening
AT schneidergunther carotidultrasoundforpulmonaryarteriovenousmalformationscreening
AT maßmannalexander carotidultrasoundforpulmonaryarteriovenousmalformationscreening
AT graberstefan carotidultrasoundforpulmonaryarteriovenousmalformationscreening
AT geisthoffurbanw carotidultrasoundforpulmonaryarteriovenousmalformationscreening